Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

about

Progabide add-on for refractory epilepsy A comparative study of progabide, valproate, and placebo as add-on therapy in patients with refractory epilepsy

P2860

Q24197717-7445D589-D3A7-43C4-B71D-EF3265CFADAE Q33622773-6DE8439F-987B-42D0-90C0-58025704DC21

P2860

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

Item

http://www.wikidata.org/entity/Q54468052

description

1984 nî lūn-bûn

@nan

1984年の論文

@ja

1984年学术文章

@wuu

1984年学术文章

@zh-cn

1984年学术文章

@zh-hans

1984年学术文章

@zh-my

1984年学术文章

@zh-sg

1984年學術文章

@yue

1984年學術文章

@zh

1984年學術文章

@zh-hant

name

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@en

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@nl

type

Item

label

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@en

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@nl

prefLabel

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@en

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@nl

P1476

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

@en

P2093

Bossi L

http://www.w3.org/2001/XMLSchema#string

Martínez-Lage JM

http://www.w3.org/2001/XMLSchema#string

Morales G

http://www.w3.org/2001/XMLSchema#string

Orofiamma B

http://www.w3.org/2001/XMLSchema#string

Viteri C

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of convulsant and anticonvulsant agents on level and metabolism of gamma-aminobutyric acid in mouse brain

Molecular mechanisms regulating the interactions between the benzodazepines and GABA receptors in the central nervous system.

Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy.

A rapid and sensitive gas-liquid chromatographic procedure for the micro determination of sodium valproate (sodium di-N-propylacetate) in plasma or serum.

Enhancement of GABA-mediated postsynaptic inhibition in cultured mammalian spinal cord neurons: a common mode of anticonvulsant action.

Characteristics of muscimol accumulation in mouse brain after systemic administration.

The two-period cross-over clinical trial.

Glutamic acid decarboxylase in Parkinson's disease and epilepsy.

The inhibitory action of beta-hydroxy-gamma-aminobutyric acid upon the seizure following stimulation of the motor cortex of the dog.

P304

586-593

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1528-1157.1984.TB03466.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eduardo Martínez-Vila

P577

1984-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

6383790

http://www.w3.org/2001/XMLSchema#string

P921

placebo

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

about

P2860

P2860

Progabide treatment in severe epilepsy: a double-blind cross-over trial versus placebo.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921